Guangzhou Tinci Materials Technology Co (002709): Morgan Stanley cuts Tinci’s target to Rmb30.30 but keeps Equal-weight as 2027 oversupply concerns appear priced in

Overview

Morgan Stanley reviews Guangzhou Tinci Materials Technology Co after updating volume and profitability assumptions. It expects a less favorable LiPF6 and electrolyte supply-demand balance in 2027, but retains an Equal-weight rating because the market is viewed as already recognizing much of the coming pressure.

Core views

Morgan Stanley expects LiPF6 and electrolyte profitability to remain under pressure in 2027 as supply growth accelerates while demand growth moderates. Tinci, Tianji and Shilei expanded capacity in 2026 amid a strong demand outlook, and the firm’s channel checks indicate that China’s LiPF capacity is running at or near full utilization during the current peak month. Morgan Stanley estimates total LiPF capacity will increase by about 24% in 2026 and another 27% in 2027. Its concern is that demand growth will slow in 2027 versus 2026, worsening the supply-demand balance. The institution nevertheless argues that the prospective downturn is broadly understood and largely priced in. Consensus forecasts for 2027e unit net profit in LiPF and electrolytes remain above the troughs reported in 2H24 and 1H25. Morgan Stanley considers this reasonable if 2027 demand growth reaches 25%, because LiPF utilization should remain high; its base case assumes overall utilization above 80%, versus below 60% in 2023 and 2024. If demand growth falls below 25%, however, electrolyte unit net profit could face additional downside pressure. Morgan Stanley raises its volume forecasts for 2026 and 2027 based on Tinci’s latest guidance, including a potential turnaround in ferric phosphate, but lowers unit-profit assumptions for faster and larger-than-expected capacity expansion. Revenue forecasts rise to Rmb32.598bn for 2026e and Rmb41.850bn for 2027e, while EBITDA estimates fall 4% and 7%, respectively. Net-income forecasts are cut 4% to Rmb4.801bn for 2026e and 11% to Rmb4.760bn for 2027e; EPS forecasts are Rmb2.36 and Rmb2.34. The firm introduces 2028 forecasts, including Rmb50.391bn revenue and Rmb5.321bn net income. The Rmb30.30 base-case target is derived from 13x 2027e P/E, replacing the prior Rmb49.00 target based on 20x 2026e P/E. The selected multiple is above the 10-12x range of the last down-cycle because Morgan Stanley expects electrolyte unit profitability to hold up better this time. In the bull case, slower capacity expansion, stronger demand and preserved market share allow electrolyte unit profit to remain near the 2026 average, supporting about 20x 2027e P/E. In the bear case, intensifying competition drives electrolyte unit profit below the Rmb800/t trough seen in 2024/25, prompting a switch to 1.2x 2027e P/B, in line with the trough valuation since 2021. Tinci remains China’s largest electrolyte producer and market-share leader, supported by long-term contracts with top-tier battery makers. Morgan Stanley expects renewed pressure on electrolyte and LiPF6 profitability in 2027-28 from continued capacity expansion, but maintains Equal-weight on the view that the likely decline is substantially reflected in the market.

Analysis framework

Morgan Stanley combines channel checks on LiPF6 utilization, capacity and demand assumptions, company volume guidance, revised earnings forecasts and scenario-based valuation. It tests base, bull and bear outcomes through different assumptions for capacity start-ups, demand growth, market share and electrolyte unit profitability.

Methodology notes

• Industry AnalysisSupply-demand framework

  LiPF6 capacity growth, demand growth and utilization analysis

  The report assesses future profitability by comparing planned supply additions with expected demand growth and translating the resulting utilization rate into pressure on electrolyte and LiPF6 unit profit.

• Valuation methodsP/E and PEG Valuation

  2027e P/E multiple valuation

  The base target applies a 13x 2027e P/E multiple, with a separate bull-case P/E multiple, to reflect expected profitability resilience relative to the prior down-cycle.

• Valuation methodsPB valuation

  Bear-case 2027e P/B valuation

  If unit profit falls below the prior-cycle trough, the report switches from earnings-based valuation to a 1.2x 2027e P/B framework.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Guangzhou Tinci Materials Technology Co (002709.SZ)

  Primary covered electrolyte and LiPF6 producer exposed to capacity-driven profitability pressure.

  Strengths

  China’s largest electrolyte producer and market-share leader, with long-term contracts from top-tier battery makers.

  Weaknesses

  Electrolyte and LiPF6 unit profitability is expected to face renewed pressure in 2027-28.

  Comparison

  Base-case 13x 2027e P/E is above the 10-12x P/E range in the prior down-cycle because unit profitability is expected to hold up better.

  Risks

  Faster-than-expected capacity start-ups and weaker demand could push unit profit below the previous down-cycle trough.

Key data

• LiPF6 capacity growth~24% in 2026; 27% in 2027Morgan Stanley estimate; capacity additions are expected to outpace a moderating demand-growth outlook.
• 2026e net incomeRmb4.801bnCut 4% versus the prior forecast.
• 2027e net incomeRmb4.760bnCut 11% versus the prior forecast.
• 2027e revenueRmb41.850bnRevised forecast, 38% above the prior estimate.
• Price targetRmb30.30Reduced 38% from Rmb49.00; based on 13x 2027e P/E.
• Base-case utilization>80%Assumes 25% demand growth in 2027, compared with below 60% overall utilization in 2023 and 2024.
• Bear-case electrolyte unit profit<Rmb800/tBelow the 2024/25 trough assumption that triggers a 1.2x 2027e P/B valuation.

Impact & implications

The report sees rising supply as the central constraint on Tinci’s 2027 earnings and valuation. Higher volume expectations do not offset lower assumed unit profitability, leading to forecast reductions and a lower target price; however, Morgan Stanley believes the anticipated downturn is sufficiently recognized to support an Equal-weight stance.

Risks

• Upside risk: new LiPF6 capacity additions do not start up on time.
• Upside risk: Tinci regains market share.
• Downside risk: capacity additions start faster than expected, driving unit net profit below the previous down-cycle level.
• Downside risk: demand growth falls below expectations.

What to watch

• LiPF6 and electrolyte spot prices.
• The timing of capacity expansion or delays in start-up.
• Electrolyte gross margins.
• Whether 2027 demand growth reaches the 25% assumption underlying high utilization.
• Tinci’s market-share trend.